B lymphocyte reconstitution after hematopoietic stem cell transplantation

Functional immaturity and slow recovery of memory CD27+ B cells

Maria Antonietta Avanzini, Franco Locatelli, Conceicao Dos Santos, Rita Maccario, Elisa Lenta, Mara Oliveri, Sebastian Giebel, Piero De Stefano, Francesca Rossi, Giovanna Giorgiani, Giovanni Amendola, Stefania Telli, Massimo Marconi

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Objective. Functional recovery of B lymphocytes after hematopoietic stem cell transplantation (HSCT) can take up to 2 years. HSCT recipients may obtain protective titers of pathogen-specific antibody through vaccination, but optimal timing of reimmunization remains to be defined. Patients and Methods. In this study, we evaluated the reconstitution of B-cell number and activity in 139 children given HSCT, by B-cell subset phenotyping and in vitro immunoglobulin (Ig) production. Results. Patients were longitudinally studied at 3, 6, 12, and 18 to 24 months after transplantation. At all time points, recipients displayed a significantly higher percentage of naive (IgD+CD27-) B cells and showed significantly lower production of stimulated in vitro Ig as compared to healthy controls. Moreover, during follow-up, we observed an increase in the proportion of patients who had CD27+ B subsets and who were able to mount in vitro Ig production greater than the 5th percentile. Conclusion. Similar to what has been described in adults, most children lack memory B cells and produce low amounts of Ig. However, the number of B cells, as well as their function, gradually recovered over time and the spread of data we observed suggests that the reimmunization schedule should be individualized for each patient. It remains to be defined in a prospective clinical study the time point at which a patient should start reimmunization. A reasonable hypothesis to be explored is the time point at which a percentage of memory B cells greater than the 5th percentile of normal controls is reached.

Original languageEnglish
Pages (from-to)480-486
Number of pages7
JournalExperimental Hematology
Volume33
Issue number4
DOIs
Publication statusPublished - Apr 2005

Fingerprint

Hematopoietic Stem Cell Transplantation
B-Lymphocytes
Immunoglobulins
B-Lymphocyte Subsets
Immunoglobulin D
Appointments and Schedules
Vaccination
Cell Count
Transplantation
Prospective Studies
Antibodies
In Vitro Techniques

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Hematology
  • Oncology
  • Transplantation

Cite this

B lymphocyte reconstitution after hematopoietic stem cell transplantation : Functional immaturity and slow recovery of memory CD27+ B cells. / Avanzini, Maria Antonietta; Locatelli, Franco; Dos Santos, Conceicao; Maccario, Rita; Lenta, Elisa; Oliveri, Mara; Giebel, Sebastian; De Stefano, Piero; Rossi, Francesca; Giorgiani, Giovanna; Amendola, Giovanni; Telli, Stefania; Marconi, Massimo.

In: Experimental Hematology, Vol. 33, No. 4, 04.2005, p. 480-486.

Research output: Contribution to journalArticle

Avanzini, MA, Locatelli, F, Dos Santos, C, Maccario, R, Lenta, E, Oliveri, M, Giebel, S, De Stefano, P, Rossi, F, Giorgiani, G, Amendola, G, Telli, S & Marconi, M 2005, 'B lymphocyte reconstitution after hematopoietic stem cell transplantation: Functional immaturity and slow recovery of memory CD27+ B cells', Experimental Hematology, vol. 33, no. 4, pp. 480-486. https://doi.org/10.1016/j.exphem.2005.01.005
Avanzini, Maria Antonietta ; Locatelli, Franco ; Dos Santos, Conceicao ; Maccario, Rita ; Lenta, Elisa ; Oliveri, Mara ; Giebel, Sebastian ; De Stefano, Piero ; Rossi, Francesca ; Giorgiani, Giovanna ; Amendola, Giovanni ; Telli, Stefania ; Marconi, Massimo. / B lymphocyte reconstitution after hematopoietic stem cell transplantation : Functional immaturity and slow recovery of memory CD27+ B cells. In: Experimental Hematology. 2005 ; Vol. 33, No. 4. pp. 480-486.
@article{b2f62a9bd58b44b3a08744251efcd3ed,
title = "B lymphocyte reconstitution after hematopoietic stem cell transplantation: Functional immaturity and slow recovery of memory CD27+ B cells",
abstract = "Objective. Functional recovery of B lymphocytes after hematopoietic stem cell transplantation (HSCT) can take up to 2 years. HSCT recipients may obtain protective titers of pathogen-specific antibody through vaccination, but optimal timing of reimmunization remains to be defined. Patients and Methods. In this study, we evaluated the reconstitution of B-cell number and activity in 139 children given HSCT, by B-cell subset phenotyping and in vitro immunoglobulin (Ig) production. Results. Patients were longitudinally studied at 3, 6, 12, and 18 to 24 months after transplantation. At all time points, recipients displayed a significantly higher percentage of naive (IgD+CD27-) B cells and showed significantly lower production of stimulated in vitro Ig as compared to healthy controls. Moreover, during follow-up, we observed an increase in the proportion of patients who had CD27+ B subsets and who were able to mount in vitro Ig production greater than the 5th percentile. Conclusion. Similar to what has been described in adults, most children lack memory B cells and produce low amounts of Ig. However, the number of B cells, as well as their function, gradually recovered over time and the spread of data we observed suggests that the reimmunization schedule should be individualized for each patient. It remains to be defined in a prospective clinical study the time point at which a patient should start reimmunization. A reasonable hypothesis to be explored is the time point at which a percentage of memory B cells greater than the 5th percentile of normal controls is reached.",
author = "Avanzini, {Maria Antonietta} and Franco Locatelli and {Dos Santos}, Conceicao and Rita Maccario and Elisa Lenta and Mara Oliveri and Sebastian Giebel and {De Stefano}, Piero and Francesca Rossi and Giovanna Giorgiani and Giovanni Amendola and Stefania Telli and Massimo Marconi",
year = "2005",
month = "4",
doi = "10.1016/j.exphem.2005.01.005",
language = "English",
volume = "33",
pages = "480--486",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - B lymphocyte reconstitution after hematopoietic stem cell transplantation

T2 - Functional immaturity and slow recovery of memory CD27+ B cells

AU - Avanzini, Maria Antonietta

AU - Locatelli, Franco

AU - Dos Santos, Conceicao

AU - Maccario, Rita

AU - Lenta, Elisa

AU - Oliveri, Mara

AU - Giebel, Sebastian

AU - De Stefano, Piero

AU - Rossi, Francesca

AU - Giorgiani, Giovanna

AU - Amendola, Giovanni

AU - Telli, Stefania

AU - Marconi, Massimo

PY - 2005/4

Y1 - 2005/4

N2 - Objective. Functional recovery of B lymphocytes after hematopoietic stem cell transplantation (HSCT) can take up to 2 years. HSCT recipients may obtain protective titers of pathogen-specific antibody through vaccination, but optimal timing of reimmunization remains to be defined. Patients and Methods. In this study, we evaluated the reconstitution of B-cell number and activity in 139 children given HSCT, by B-cell subset phenotyping and in vitro immunoglobulin (Ig) production. Results. Patients were longitudinally studied at 3, 6, 12, and 18 to 24 months after transplantation. At all time points, recipients displayed a significantly higher percentage of naive (IgD+CD27-) B cells and showed significantly lower production of stimulated in vitro Ig as compared to healthy controls. Moreover, during follow-up, we observed an increase in the proportion of patients who had CD27+ B subsets and who were able to mount in vitro Ig production greater than the 5th percentile. Conclusion. Similar to what has been described in adults, most children lack memory B cells and produce low amounts of Ig. However, the number of B cells, as well as their function, gradually recovered over time and the spread of data we observed suggests that the reimmunization schedule should be individualized for each patient. It remains to be defined in a prospective clinical study the time point at which a patient should start reimmunization. A reasonable hypothesis to be explored is the time point at which a percentage of memory B cells greater than the 5th percentile of normal controls is reached.

AB - Objective. Functional recovery of B lymphocytes after hematopoietic stem cell transplantation (HSCT) can take up to 2 years. HSCT recipients may obtain protective titers of pathogen-specific antibody through vaccination, but optimal timing of reimmunization remains to be defined. Patients and Methods. In this study, we evaluated the reconstitution of B-cell number and activity in 139 children given HSCT, by B-cell subset phenotyping and in vitro immunoglobulin (Ig) production. Results. Patients were longitudinally studied at 3, 6, 12, and 18 to 24 months after transplantation. At all time points, recipients displayed a significantly higher percentage of naive (IgD+CD27-) B cells and showed significantly lower production of stimulated in vitro Ig as compared to healthy controls. Moreover, during follow-up, we observed an increase in the proportion of patients who had CD27+ B subsets and who were able to mount in vitro Ig production greater than the 5th percentile. Conclusion. Similar to what has been described in adults, most children lack memory B cells and produce low amounts of Ig. However, the number of B cells, as well as their function, gradually recovered over time and the spread of data we observed suggests that the reimmunization schedule should be individualized for each patient. It remains to be defined in a prospective clinical study the time point at which a patient should start reimmunization. A reasonable hypothesis to be explored is the time point at which a percentage of memory B cells greater than the 5th percentile of normal controls is reached.

UR - http://www.scopus.com/inward/record.url?scp=20144364876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20144364876&partnerID=8YFLogxK

U2 - 10.1016/j.exphem.2005.01.005

DO - 10.1016/j.exphem.2005.01.005

M3 - Article

VL - 33

SP - 480

EP - 486

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 4

ER -